Evidence map›Paper›PMID 31171569›Full record

ArticleCold Spring Harbor molecular case studies2019

De novo loss-of-function variants in

Elizabeth S Barrie, Maria P Alfaro, Ruthann B Pfau, Melanie J Goff, Kim L McBride, Kandamurugu Manickam, Erik J Zmuda

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Cold Spring Harbor molecular case studies, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Case Report: AFrontiers in pediatrics · 2026
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Case report: AFrontiers in pediatrics · 2023
    Article
  9. Review
  10. Article
  11. NSD2 as a Promising Target in Hematological Disorders.International journal of molecular sciences · 2022
    Review
  12. Review
  13. Review
  14. Reprogramming of the epigenome in neurodevelopmental disorders.Critical reviews in biochemistry and molecular biology · 2022
    Review
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Elizabeth S BarrieThe Institute for Genomic Medicine at Nationwide Children's Hospital, Columbus, Ohio 43215, USA.ORCID 0000-0002-1146-5001
Maria P AlfaroThe Institute for Genomic Medicine at Nationwide Children's Hospital, Columbus, Ohio 43215, USA.
Ruthann B PfauThe Institute for Genomic Medicine at Nationwide Children's Hospital, Columbus, Ohio 43215, USA.
Melanie J GoffDivision of Genetic and Genomic Medicine.
Kim L McBrideDivision of Genetic and Genomic Medicine.
Kandamurugu ManickamDivision of Genetic and Genomic Medicine.
Erik J ZmudaThe Institute for Genomic Medicine at Nationwide Children's Hospital, Columbus, Ohio 43215, USA.
Nationwide Children's Hospital · USInstitut thématique Génétique, génomique et bioinformatique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Wolf-Hirschhorn syndrome (WHS) is a rare but recurrent microdeletion syndrome associated with hemizygosity of an interstitial segment of Chromosome 4 (4p16.3). Consistent with historical reports in which overlapping deletions defined a minimal critical region in WHS patients, recent reports from exome sequence analysis have provided further evidence that haploinsufficiency of a specific gene within this critical region,

Indexed as

Child, PreschoolChromosome DeletionDevelopmental DisabilitiesFemaleHistone-Lysine N-MethyltransferaseHumansInfantIntellectual DisabilityLoss of Function MutationMalePhenotypeRepressor ProteinsWolf-Hirschhorn SyndromeHistone-Lysine N-MethyltransferaseNSD2 protein, humanRepressor Proteinsfailure to thrive in infancygeneralized neonatal hypotoniamicrocephalymoderate intrauterine growth retardationshort stature

Identifiers

PMID31171569
PMCPMC6672030
OpenAlexW2966574966

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.